Our new website is coming soon, give it a try now and let us have your feedback. Take me to the Beta



Register
Login:
Share:
Email Facebook Twitter


TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake
Exclusive: Hardman & Co Investor Forum - Severn Trent, Calculus Capital, Volta Finance, Residential




Share Price Information for Motif Bio (MTFB)


Share Price: 2.65Bid: 2.66Ask: 2.79Change: -0.075 (-2.75%)Faller - Motif Bio
Spread: 0.13Spread as %: 4.89%Open: 2.80High: 2.80Low: 2.59Yesterday’s Close: 2.725

Motif Bio Plc Ord 1P

Motif Bio is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
2.65
Share Price SpacerBid
2.66
Share Price SpacerAsk
2.79
Share Price SpacerChange
-2.75%-0.075
Share Price SpacerVolume
5,702,801
Share Price SpacerOpen
2.80
Share Price SpacerHigh
2.80
Share Price SpacerLow
2.59
Share Price SpacerClose
2.725
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 342.49m £9.08m 50,000

52 Week High 44.90 52 Week High Date 6-FEB-2019
52 Week Low 2.40 52 Week Low Date 24-JUN-2019

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
170 3,672,126 1,956,749 -0.673 -3.94 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

25-Jun-19
16:29:17
2.7746
5,000
Buy* 
2.65
2.79
138.73
Trade Type:
Ordinary

25-Jun-19
16:27:14
2.65
1,680
Sell* 
2.65
2.79
44.52
Trade Type:
Automatic execution

25-Jun-19
16:27:14
2.65
3,120
Sell* 
2.65
2.79
82.68
Trade Type:
Automatic execution




View more Motif Bio trades >>

Directors Deals for Motif Bio (MTFB)
Trade DateActionNotifierPriceCurrencyAmountHolding
02-Oct-15Buy
Trade Notifier Information for Motif Bio
John Wilbur Stakes III held the position of Non-Executive Director at Motif Bio at the time of this trade.
 John Wilbur Stakes III
60GBX100,000171850
02-Apr-15Notification of Holding
Trade Notifier Information for Motif Bio
Richard Cecil Eversfield Morgan held the position of Non-Executive Chairman at Motif Bio at the time of this trade.
 Richard Cecil Eversfield Morgan
00190916
02-Apr-15Notification of Holding
Trade Notifier Information for Motif Bio
Charlotta Ginman-Jones held the position of Non-Executive Director at Motif Bio at the time of this trade.
 Charlotta Ginman-Jones
00125000
View more Motif Bio directors dealings >>


qweqweqwe
Posts: 685
Opinion:No Opinion
Price:2.65
RE: Is lasting until Sept feasible?
Tue 22:56
Hey Scott,

I can understand your bitterness as you’ve probably lost a lot of money, but if you couldn’t make money going long on this share then see if you can make money going short? It doesn’t have to be a huge amount so that at least you’ll be contempt a little when you can say to yourself “I told you so”. And even if you can’t make money going short, then your losses would be minimal compared to the satisfaction you would get from being right. DYOR

Or alternatively, take a break from this share and focus on something that make stop happy and doesn’t remind you of the losses you’ve incurred.

Everyone has a right to air their opinion on this BB and I won’t stop you or anyone else from airing their opinions.

Good luck, and I hope everything works out well for you.
ScottPalmer250
Posts: 528
Opinion:No Opinion
Price:2.65
RE: Is lasting until Sept feasible?
Tue 19:20
Will they have form on being overly optimistic....just look at their only asset so it wouldn’t be without good reason you are deducing this outcome
Rhambo
Posts: 2,081
Opinion:No Opinion
Price:2.65
RE: Is lasting until Sept feasible?
Tue 19:15
@ScottPalmer250 no I am not saying it is lying, you can't lie about a 'hope' to achieve something. I am saying it looks unrealistic and they haven't detailed how they will achieve such a vastly reduced burn rate. Without such information, I can only deduce that they are being optimistic
ScottPalmer250
Posts: 528
Opinion:No Opinion
Price:2.65
RE: Big News should nudge FDA
Tue 19:14
FDA have indicated they clearly need substantial new trials sadly no use of Iclaprim anytime soon
YoYoY
Posts: 474
Opinion:No Opinion
Price:2.65
RE: Big News should nudge FDA
Tue 18:51
2 Dec 2015 - Jul 15: The FDA has designated Motif Bio's novel antibiotic iclaprim as a ... and MDRSP (multi-drug resistant Streptococcus pneumoniae)
View more share chat for Motif Bio (MTFB) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk









Home  |  Contact Us  |  About Us  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy  |  Mobile Site  |  About this website design


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.